BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23021320)

  • 1. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
    Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
    Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression.
    Aguirre I; Carretero B; Ibarra O; Kuhalainen J; Martínez J; Ferrer A; Salva J; Roca M; Gili M; Montoya P; Garcia-Toro M
    J Affect Disord; 2011 May; 130(3):466-9. PubMed ID: 21093060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
    Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
    J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    J Nerv Ment Dis; 2007 May; 195(5):378-81. PubMed ID: 17502802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study.
    Weaver L; Rostain AL; Mace W; Akhtar U; Moss E; O'Reardon JP
    J ECT; 2012 Jun; 28(2):98-103. PubMed ID: 22551775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
    Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
    J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
    Lisanby SH; Husain MM; Rosenquist PB; Maixner D; Gutierrez R; Krystal A; Gilmer W; Marangell LB; Aaronson S; Daskalakis ZJ; Canterbury R; Richelson E; Sackeim HA; George MS
    Neuropsychopharmacology; 2009 Jan; 34(2):522-34. PubMed ID: 18704101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
    Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
    Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vascular depression using repetitive transcranial magnetic stimulation.
    Jorge RE; Moser DJ; Acion L; Robinson RG
    Arch Gen Psychiatry; 2008 Mar; 65(3):268-76. PubMed ID: 18316673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.